This activation occurs independently of HER2, HER3, and epidermal growth factor receptor (EGFR), and is coupled with the loss of the phosphatase and tensin homolog (PTEN) tumor suppressor gene, one of the most mutated genes in BC (Fig. 3) [48–50]. The gene discussed is ERBB2; the disease is breast cancer.